PATENT CLAIM ANALYSIS

Application Number: 15879806
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "465000"]

Abstract:
Disclosed herein are pharmaceutically acceptable rapid dissolve vaginal tablet compositions comprising one or more active pharmaceutical ingredients suitable for therapy via topical action or systemic absorption, and methods of making and using such compositions.

Claim (Index 9):
The pharmaceutical composition of claim  1 , further comprising at least one surfactant selected from the group consisting of DL-alpha tocopherol, CAPTEX 200, Tween 20 Tween 80, Vitamin E TPGS, Capryol 90, CREMOPHOR EL, CARBITOL, PEG 400, lecithin, BRIJ 92, LABRASOL, triacetin, sodium lauryl sulfate, ethylene glycol monostearate, polysorbates PLURONIC\u00ae, GELUCIRE\u00ae, LABRAFIL\u00ae, LABRASOL\u00ae , IMWITOR\u00ae, sodium lauryl salicylate, and sodium dodecyl sulfate, or mixtures thereof.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 86.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14917125', '15387317', '14743026', '13974725', '10827106']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6924650966413379
- 35 USC 102 Novelty (BERT): 0.5107428386141494
- Combined Prediction Score: 0.6742928708386191
- Mean Citation Score: 252.85325200000003
- Max Citation Score: 272.79074
- Similarity Product: 200.8932329011023

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test